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Background: Nanoclusters of the C-type lectin DC-SIGN on dendritic cells act as docking sites for viral binding.
Results: The extracellular neck region is responsible for nanocluster formation and necessary for virus binding.
Conclusion: Heterogeneous nanocluster density and spatial distribution confer broad binding capabilities to DC-SIGN.
Significance: Insights into how virus receptors preorganize and assemble into docking platforms contribute to clarifying
mechanisms of virus entry.
The C-type lectin DC-SIGN expressed on dendritic cells
(DCs) facilitates capture and internalization of a plethora of dif-
ferent pathogens. Although it is known thatDC-SIGNorganizes
in nanoclusters at the surface of DCs, the molecular mecha-
nisms responsible for this well defined nanopatterning and role
in viral binding remain enigmatic. By combining biochemical
and advanced biophysical techniques, including optical super-
resolution and single particle tracking, we demonstrate that
DC-SIGN intrinsic nanoclustering strictly depends on its
molecular structure. DC-SIGN nanoclusters exhibited free,
Brownian diffusion on the cell membrane. Truncation of the
extracellular neck region, known to abrogate tetramerization,
significantly reduced nanoclustering and concomitantly
increased lateral diffusion. Importantly, DC-SIGN nanocluster
dissolution exclusively compromised binding to nanoscale size
pathogens. Monte Carlo simulations revealed that heterogene-
ity on nanocluster density and spatial distribution confers
broader binding capabilities to DC-SIGN. As such, our results
underscore a direct relationship between spatial nanopattern-
ing, driven by intermolecular interactions between the neck
regions, and receptor diffusion to provide DC-SIGN with the
exquisite ability to dock pathogens at the virus length scale.
Insight into how virus receptors are organized prior to virus
binding and how they assemble into functional platforms for
virus docking is helpful to develop novel strategies to prevent
virus entry and infection.
Dendritic cells (DCs)4 constitute a specific group of profes-
sional antigen-presenting leukocytes that link the innate and
adaptive branches of the immune response by virtue of their
capacity to recognize pathogen-specific structures (1). Imma-
ture DCs (imDCs) migrate from the blood into tissues, where
they detect foreign antigens. Upon antigen recognition, imDCs
are activated andmigrate to the lymph nodes, where they pres-
ent antigen-derived peptides to naive T lymphocytes and
induce an effective immune response (2–4). For efficient
pathogen recognition, imDCs are equipped with a large num-
ber of lectin and lectin-like receptors on the cellular membrane
that bind to highmannose structures present on the surfaces of
a broad range of pathogens, including viruses, bacteria, yeast,
and parasites (5, 6). Because DCs can be manipulated ex vivo,
numerous efforts have been undertaken for exploiting the
extraordinary binding capabilities of lectin-like receptors to
target antigens directly to DCs in vivo, potentially increasing
the effectiveness of antitumor and antiviral vaccines (7, 8).
Dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-
SIGN; CD209) is a type II membrane C-type lectin receptor
abundantly expressed in vivo on myeloid DC and macrophage
populations (9, 10) as well as on in vitro generated monocyte-
derived DCs and activated macrophages (10–12). DC-SIGN is
responsible for the binding and uptake of a multitude of patho-
gens, such as HIV-1 (13), ebola virus (14), hepatitis C virus (15),
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Supplemental Material can be found at:
Candida albicans (16), and Mycobacterium tuberculosis (17)
via mannan- and Lewis X oligosaccharide-dependent interac-
tions. More recently, it has been shown that upon recognition
ofmannan or Lewis X carbohydrates, DC-SIGN associates with
distinct signalingmolecules to induce differential production of
cytokines that in turn lead to enhancement or suppression of
proinflammatory responses (18). The mechanisms by which
these diverging signaling pathways are generated remain amys-
tery, although it has been suggested that the molecular struc-
ture of DC-SIGN might be altered upon binding to the two
different carbohydrates.
Structurally, DC-SIGN is a tetrameric transmembrane pro-
tein, with each subunit comprising a long extracellular part
with a carbohydrate recognition domain (CRD), a 7.5 tan-
dem repeat of 23 amino acids forming the neck region, and a
transmembrane part followed by a cytoplasmic tail containing
recycling and internalization motifs (19–20). Analysis of
recombinant molecules and hydrodynamic and surface force
measurements revealed that the neck region of DC-SIGN is
responsible for its tetramerization (21–23), enabling the forma-
tion of CRD multibinding sites and increasing the interaction
strength with specific ligands (23). Based on these results, it has
been proposed that the neck configuration is likely to play a
significant role in pathogen capture (23).
Using transmission electron microscopy (TEM) and near-
field optical nanoscopy, we previously showed that DC-SIGN
forms nanoclusters on the membrane of fixed imDCs far
beyond mere tetramerization (11, 24, 25). These results have
been recently validated on living imDCs (26) and on several cell
lines transfected with DC-SIGN (26, 27). Importantly, tight
spatial ordering of DC-SIGN in nanoclusters resulted crucial
for binding and internalization of HIV-1 (11). However, how
DC-SIGN achieves such a refined level of spatial control is
largely unknown. Although DC-SIGN has been shown to par-
tially associate with lipid rafts, cholesterol extraction did not
alter the integrity of the nanoclusters (11). Similarly, DC-SIGN
nanocluster formation and/or stability do not require interac-
tions with the cortical cytoskeleton (27) or association with
tetraspanins (27). Recently, it has been hypothesized that large
DC-SIGNdomains (i.e. microclusters) could be formed and sta-
bilized through interactions between the CRDs and yet uniden-
tified extracellular components because deletion of the CRD
moiety abrogated DC-SIGN microclustering (28). However,
because these experiments were performed using diffraction-
limited confocal microscopy, it is not clear whether the nano-
clustering capacity of DC-SIGN also requires the presence of
the CRD. Thus, despite the importance of DC-SIGN nanoclus-
tering in pathogen recognition, the studies performed so far
have not yet provided conclusive evidence to explain the origin
for this well defined organization.
Here we combined biochemical assays, superresolution opti-
cal nanoscopy, single particle tracking, andMonte Carlo simu-
lations of different DC-SIGN mutants to elucidate the mecha-
nisms leading to DC-SIGN nanoclustering and to correlate
their role with viral binding capacity. Our results reveal that
homophilic interactions mediated by the neck region of DC-
SIGN are responsible for its nanoclustering and enhanced
virus-binding ability.
EXPERIMENTAL PROCEDURES
Cells and DNA Constructs—CHO cell lines stably expressing
DC-SIGN-wt, -CRD, -35, and -Rep were established by
LipofectamineTM 2000 transfection. Human imDCs were gen-
erated from buffy coats of healthy donors as reported previ-
ously (29). Plasmids used in this study were pcDNA-3 carrying
the DC-SIGN-wt or deletion mutants. These constructs have a
short C-terminal AU-1 tag and were constructed as already
published (30).
Binding Assays—Binding of CHO cells to soluble Alexa647-
mannan was performed as follows. 50,000 cells were incubated
with 50 g/ml Alexa647-mannan in 20 mM Tris, pH 8.0, con-
taining 150 mM NaCl, 1 mM CaCl2, 2 mM MgCl2, and 1% BSA
(TSA buffer) for 30 min on ice in the presence or absence of 20
g/ml anti-DC-SIGN blocking mAb (AZN-D1) or 100 g/ml
unlabeled mannan. After thorough washing in PBS, the per-
centage of cells that had bound mannan was detected by flow
cytometry using the FACSCaliburTM flow cytometer (BD Bio-
sciences). The values represent themean S.D. of duplicates of
one representative experiment of three. Binding to gp120-
coated beads was performed as already reported (11). Briefly,
streptavidin-modified TransFluorSpheres (505/515 nm, 40-nm
diameter; Molecular Probes) were coated with recombinant
biotinylated gp120 (HIV-1 III B; ImmunoDiagnostics, Inc.,
Woburn, MA) and were added to 50,000 cells in a ratio of 20
beads/cell in TSA buffer, and the suspension was incubated for
30 min at 37 °C. When necessary, cells were preincubated with
20 g/ml blocking mAb or 2 mM EDTA for 10 min at room
temperature. Binding was determined by measuring the per-
centage of cells that have bound fluorescent beads by flow
cytometry. Binding to FITC-conjugated zymosan was per-
formed as already described (16). Briefly, CHO transfectants
were incubated with FITC-labeled zymosan particles in the
absence or the presence of mannan (100 g/ml) or anti-DC-
SIGNmAb AZN-D1 (20 g/ml) in TSA buffer. After 30 min of
incubation at 37 °C, cell-zymosan conjugates were analyzed by
flow cytometry, and the percentage of CHO cells that had
acquired an FITC signal was quantified by flow cytometry.
Antigen Internalization Assay—The internalization assay
was performed as already reported (31). Briefly, CHO cell lines
stably expressing DC-SIGN wild type or the deletion mutants
were incubated with anti-DC-SIGN mAb hD1 (5 g/ml) in
serum-free medium for 20 min on ice. After washing the
unboundmAb in ice-coldmedium, half of the cells were further
incubated for 15 min on ice to prevent internalization, whereas
the other half was shifted to 37 °C for 15 min to induce inter-
nalization. Subsequently, cells were placed back on ice to stop
internalization, washed in ice-cold PBS containing 3%BSA, and
incubated with phycoerythrin-conjugated goat anti-human
antibodies for 20min on ice to stain themAb still present at the
cell surface. Unbound Abs were washed away, and cells were
fixed in 1% formaldehyde. The mean fluorescence (MF) of the
sampleswasmeasured by flow cytometry, and the percentage of
internalized mAb was calculated as ((MF at 37 °C  MF at
4 °C)/MF at 4 °C) 100. The normalization to the fluorescence
intensity at the steady state (4 °C) prevents oscillations in the
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expression levels from affecting the percentage of internaliza-
tion. Isotype controls were always included.
Gold Labeling ofWhole-mount Samples—CHO transfectants
were allowed to adhere and spread on glass coverslips covered
by a thin layer of Formvar for 1 h at 37 °C and immediately fixed
with 1% paraformaldehyde for 15 min. After two washing steps
with PBS and a subsequent incubation (60min at room temper-
ature) with blocking buffer (PBS, 0.1% glycine, 1% BSA, and
0.25% gelatin) to reduce specific background, the specimens
were incubated for 30minwith primary antibodies (DCN46Ab
(Pharmingen) for DC-SIGN-wt, -CRD, and -35 or anti-AU1
Ab (Covance) for DC-SIGN-Rep) in blocking buffer on ice,
rinsed in PBS, and fixed in 1% paraformaldehyde and 0.1%
glutaraldehyde for 15 min. After two washing steps with PBS
and blocking buffer, the samples were incubated with rabbit
anti-mouse IgG (to detect mAb) for 30min on ice. A final incu-
bation with 10-nm diameter gold-labeled Protein A (to detect
polyclonal antibodies) was performed, followed by final fixation
in 1% glutaraldehyde in phosphate buffer for 20 min at room
temperature.
To exclude the possibility that the observed difference in
nanoclusters was not an artifact of the Ab chosen, anti-AU1 as
well as anti-DC-SIGN AZN-D1 and DCN46 antibodies have
been used for labeling and comparing DCSIGN wild type and
the different mutants. More specifically, whereas anti-AU1 Ab
was used to label all DC-SIGN molecules (because all con-
structs bear the AU1 tag), the anti-CRD Ab AZN-D1 was used
to label all DC-SIGNmolecules except the-CRDmutant, and
the anti-neckAbDCN46was applied to label all DC-SIGNmol-
ecules except the -Repeat mutant (31, 32). When anti-AU1,
AZN-D1, and DCN46 labeling were compared for the
DC-SIGN wild type, no significant differences in the nanoclus-
tered organization of this receptor were observed (see supple-
mental Fig. S1).
Digital TEM images were processed by custom-written soft-
ware based onMatlab. See the supplementalMethods text for a
full description of sample imaging and analysis.
Sample Preparation for Superresolution Nanoimaging—
CHO and imDC cells were plated on glass coverslips and fixed
with 4% paraformaldehyde and 0.2% glutaraldehyde for 2 h at
room temperature. After blocking of the Fc receptors with 2%
human serum, the cells were stained with 30 nM DCN46 Ab
(Pharmingen) or anti-AU1 Ab (Covance) for 30 min at room
temperature. Secondary Ab labeling was performed with 30 nM
Alexa Fluor 488-labeled goat anti-mouse Ab (Invitrogen) for 30
min at room temperature. Washing steps were performed with
cold PBS buffer (1). Isotype controls were performed in every
experiment in order to rule out nonspecific Ab binding.
Superresolution images of DC-SIGN on fully intact cell
membranes were obtained using a commercial CW-STED sys-
tem (Leica Microsystems) or a custom confocal/near-field
scanning optical microscopy (NSOM) set-up. Brightness and
spot sizes frommultiple images were extracted using a custom-
written software based onMatlab. See the supplemental Meth-
ods for a full description of sample preparation, imaging, and
analysis.
Single Qdot Tracking—CHO and imDC cells were stained at
sublabeling conditions with anti-human DC-SIGN Fab frag-
ments, generated from DCN46 mAb or monovalent anti-hu-
man AU1 antibodies. The Fab fragments and the monovalent
antibodies were biotinylated and linked to streptavidin-coated
quantum dots (Qdot655, Invitrogen). Samples were imaged
using a custom-made single molecule epimicroscope. Movies
were recorded on the upper side of the cellmembrane at 30–60
Hz frame rates. A full description of the sample preparation,
experimental procedure, and trajectory analysis is provided in
the supplemental Methods.
RESULTS
Mutated DC-SIGN Forms Are Functional but Have
Impaired Virus-binding Capacity—We previously showed
that DC-SIGN expressed in CHO cells serves as a valid model
system to study binding, internalization, and trafficking of dif-
ferent antigens targeted to DC-SIGN, recapitulating its essen-
tial activities on imDCs (33, 34). We thus produced three dif-
ferent DC-SIGN mutants by deletion of specific regions and
stably transfected them in CHO cells to investigate their effect
on pathogen binding (Fig. 1A). The mutants are denoted as
CRD (lacking the CRD domain), Rep (lacking the tandem
repeats in the extracellular neck region), and 35 (lacking the
first 35 amino acids from the N terminus in the cytoplasmic
tail). We evaluated the functionality and binding capability of
the stable transfectants to soluble ligands and virus-sized and
micrometer-sized objects. Whereas DC-SIGN-wt, -Rep, and
-35 bind to fluorescent soluble mannan, the lack of the CRD
expectedly prevents binding, consistent with the fact that DC-
SIGN-mediated interactions occur through the CRD (20) (Fig.
1B). The addition of blocking antibodies or competing soluble
mannan significantly reduces the binding in all cases, showing
DC-SIGN specificity. These results confirm that DC-SIGN-wt,
-Rep, and -35 are all functional on CHO cells and further-
FIGURE 1. Mutated DC-SIGN forms are functional but have impaired
virus-bindingcapacity.A, schematicsofDC-SIGN-wtandcell surfaceexpres-
sion levels of DC-SIGN-wt and mutants on stably transfected CHO cells as
determinedbyFACSanalysis. Theblackhistogram represents the isotypecon-
trol, and the red histogram indicates the specific staining with anti-DC-SIGN
Ab (anti-AU1). B–D, binding of soluble fluorescent Alexa647-mannan (B),
gp120-coated fluorescent nanobeads (40 nm Ø) (C), and micrometer-sized
FITC-zymosan (D) to CHO cells expressing DC-SIGN-wt or mutants was mea-
sured by FACS. Specificity was determined bymeasuring binding in the pres-
ence of anti-DC-SIGN blocking Ab (AZN-D1) or Ca2-chelating agent EDTA or
soluble non-fluorescent mannan. One representative experiment of three is
shown. Values represent the average of duplicate experiments with corre-
sponding S.D. (error bars).
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more show that the CRD is available for binding even in the
absence of the neck region.
To investigate the DC-SIGN capability for virus docking, we
carried out binding assays to gp120-coated nanobeads (40 nm
in diameter; Fig. 1C) having a size comparable with HIV-1 (35).
Interestingly, significant binding is only observed on
DC-SIGN-wt and -35. Although a lack of binding is expected
for DC-SIGN-CRD, the complete absence of binding of
DC-SIGN-Rep indicates a key role for the neck region in
securing interactions with nanometer-sized particulate anti-
gens. This was further confirmed by using real HIV-1 virus
particles, which were bound by CHO cells expressing
DC-SIGN-wt and not by DC-SIGN-Rep (supplemental Fig.
S4), thus validating the use of nanobeads as virus-like particles
and in agreement with previous studies from our and other
laboratories (30, 34). To further investigate the capability of
binding to large objects, we performed similar experiments
usingmicrometer-sized zymosan particles (yeast cell walls; Fig.
1D). High binding was retrieved for DC-SIGN-wt and all of the
mutants, except for DC-SIGN-CRD, in similar fashion as
found for the soluble ligand. Note that the somewhat lower
binding of DC-SIGN-35 in all cases is due to its lower expres-
sion level as compared with -wt, -CRD, and -Rep (Fig. 1A).
These results show that whereas binding of DC-SIGN and its
mutants to soluble ligands and large particles occurs with sim-
ilar efficiency, the neck region of DC-SIGN is crucial to ensure
binding of small virus-sized particles.
The Cytoplasmic Tail Impacts on DC-SIGN Clathrin-depen-
dent Internalization—We previously showed that DC-SIGN-
mediated endocytosis of virus-like particles occurs via clathrin
(33, 34). Therefore, we sought to investigate the effect of struc-
tural mutations on DC-SIGN-mediated endocytosis. Trunca-
tion of the neck region (DC-SIGN-Rep) does not affect anti-
gen internalization compared with DC-SIGN-wt (Fig. 2A). In
contrast, deletion of the cytoplasmic tail (DC-SIGN-35) sig-
nificantly reduced internalization (Fig. 2A), supporting previ-
ous findings obtained on DC-SIGN-35 expressed on Raji cells
and incubated with HIV-1 virions (36). Subsequently, we used
confocal imaging to determine the degree of colocalization of
anti-DC-SIGN mAbs and clathrin before and 10 min after
endocytosis triggering (Fig. 2B). Colocalization with clathrin
was not observed for DC-SIGN-wt or the two mutants investi-
gated (DC-SIGN-Rep and DC-SIGN-35) in the basal state.
Triggering of endocytosis by shifting the temperature to 37 °C
for 10 min induced significant colocalization with clathrin for
DC-SIGN-wt and DC-SIGN-Rep but not for DC-SIGN-35,
as quantified using the Pearson correlation coefficient (Fig. 2C).
Our data thus show that the cytoplasmic tail of DC-SIGN is
crucial for clathrin-dependent endocytosis, whereas the neck
region has no major influence on internalization.
TheNeckRegion Is Required forDC-SIGNNanoclustering—It
is known that DC-SIGN forms nanoclusters on the cell surface
of imDCs and of several cell lines (11, 24–27). To investigate
whether a potential relationship might exist between the
molecular structure of DC-SIGN and its nanoclustering capac-
ity, we performed TEM on whole-mount samples of CHO cells
(Fig. 3A). TEM images of immunogold-labeled DC-SIGN-wt
showed a non-homogeneous receptor distribution over the cell
membrane, characterized by regions of closely grouped parti-
cles (Fig. 3A, top). Similar nanoclustered organization was
FIGURE 2. The cytoplasmic tail impacts on DC-SIGN clathrin-dependent internalization. A, CHO cells stably transfected with DC-SIGN constructs were
incubatedwith anti-DCSIGNmAbhD1 at 4 °C,washed, and incubated for 30min at 37 °C to induce endocytosis. After stainingwith a fluorescent secondaryAb,
the sampleswere analyzedby flow cytometry. Thepercentage of internalizationwas calculated as indicated in the supplementalMethods. One representative
experimentperformed in triplicate of three is shown.B, CHO transfectantswere incubatedwithhD1at 4 °C,washed, andbriefly incubatedwith isotype-specific
Alexa647 (red)-conjugated secondary Abs at 4 °C. After washing, cells were kept on ice (0 min at 37 °C) or shifted for 10min at 37 °C to induce endocytosis (10
min at 37 °C). After fixation and permeabilization, clathrin (green) was labeled, and the sample was analyzed by confocal microscopy on a Leica DMRA
fluorescence microscope equipped with a COHU CCD camera. The pictures are enlarged areas taken from representative cells. Scale bar, 5 m. C, Pearson
colocalization coefficient plot of DC-SIGN and clathrin. Values S.E. (error bars) are the average of multiple images from several cells in at least three different
experiments. *, p 0.01, t test.
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found for the CRD and the 35 mutants (supplemental Fig.
S2). In contrast, a significantly more disperse distribution was
observed for the Rep mutant (Fig. 3A, bottom). We analyzed
the images by means of a cluster-searching algorithm that dis-
criminates between isolated and clustered receptors by recur-
sively comparing the interparticle distances with a threshold
value of 80 nm (see supplemental Methods and Fig. S3). Quan-
tification of the DC-SIGN-wt, -CRD, and -35 gold particle
distributions showed that the large majority (80%) of recep-
tors are organized in nanoclusters and that this percentage
drops to60% for DC-SIGN-Rep (Fig. 3B). Because two par-
ticles closer than 80 nm from each other are already defined as
a cluster by the algorithm (supplemental Fig. S3 and supple-
mental Methods), we further inquired whether the degree of
clustering of DC-SIGN-wt differed from that of the mutants.
For this, we calculated the distribution of the number of parti-
cles per nanocluster (nclust). The cluster probability distribu-
tions are similar forDC-SIGN-wt, -CRD, and -35, indicating
that the CRD and the cytoplasmic tail of DC-SIGN do not play
a role inDC-SIGNnanoclustering (Fig. 3C). In remarkable con-
trast, the large majority of the DC-SIGN-Rep nanoclusters
contain at themost 2–3 particles (Fig. 3C). Beyond these values,
the distribution of cluster sizes decays very rapidly, significantly
overlapping with that of simulations of random organization.
Indeed, the probability of finding clusters of four particles is
nearly 6-fold lower in the case of DC-SIGN-Rep with respect
to DC-SIGN wild type (and the other mutants) and 10-fold
lower for clusters larger than eight particles (Fig. 3C). Alto-
gether, these data demonstrate that deletion of the neck region
severely reduces the aggregation state of DC-SIGN at the nano-
scale, indicating that the neck region is crucial to maintain
nanocluster integrity.
Superresolution Optical Nanoscopy Reveals Differences in the
Spatial Organization of DC-SIGN That Depend on Its Molecu-
lar Structure—AlthoughTEMshows the presence of DC-SIGN
nanoclustering on CHO cells, in a similar fashion as already
reported for imDC (11), steric hindrance between Abs and/or
gold beads can induce non-saturated receptor labeling, poten-
tially leading to an underestimation of nanoclustering. There-
fore, to confirm DC-SIGN-wt nanoclustering and its abroga-
tion for DC-SIGN-Rep, we performed extensive nanoscale
imaging on fully intact CHO cells and imDCs using stimulated
emission depletion (STED) as well as NSOM (see supplemental
Methods).
Representative confocal and STED images of DC-SIGN-wt
on the membrane of fixed CHO cells are shown in Fig. 4, A and
B.With an optical resolution of 95 nm, STED reveals individual
DC-SIGN spots well separated on the cell membrane and sig-
nificantly brighter than those on the glass substrate, which arise
from sparsely and nonspecifically attached individual antibod-
ies (Fig. 4B). Similar results were obtained when imaging DC-
SIGN on monocyte-derived imDCs using a combined single
molecule confocal/NSOM set-up at an optical resolution of 90
nm (Fig. 5, A and B) (24, 25). In contrast, significantly weaker
florescent spots were retrieved when performing STED imag-
ing of DC-SIGN-Rep on CHO cells (Fig. 4, C and D). The
physical size of the spots was determined frommultiple super-
resolution images by directly measuring their full width at half-
maximum (Fig. 4E). In full agreement with our TEM data, the
size distribution of DC-SIGN-Rep spots markedly shifted
toward smaller diameters compared with DC-SIGN-wt, being
similar in size to the STED resolution (Fig. 4E, inset), consistent
with a strong reduction of nanoclustering or its complete abro-
gation.On the other hand, fluorescent spots ofDC-SIGN-wt on
CHOcells and endogenousDC-SIGNon imDCs exhibited sim-
ilar average sizes (180 nm) and comparable size distributions
(Fig. 5, C and D). Brightness analysis (see supplemental Meth-
ods) to estimate the number of molecules per fluorescent spot
confirmed nanoclustering ofDC-SIGN-wtwith amean value of
7.5 (S.D.  2.7) molecules/nanocluster. This value reduced to
1.8 (S.D.  0.8) in the case of DC-SIGN-Rep. Collectively,
these results confirm that the neck region ofDC-SIGNcrucially
affects its nanocluster capacity. Because the neck region is also
imperative for DC-SIGN tetramerization (21, 37), our data
indicate that intermolecular interactions mediated by the neck
region of DC-SIGN regulate different hierarchical levels of
receptor spatial organization on the cell membrane. Together
with the reduced binding capability to virus-sized particles
observed for DC-SIGN-Rep, our data establish a direct rela-
tionship between nanoclustering formation and the exquisite
ability of DC-SIGN to dock pathogens at the virus length scale.
DC-SIGN Nanoclusters Are Mobile on CHO Cells and
imDCs—Recent reports on DC-SIGN expressed on NIH-3T3
cells and imDC showed an unusual stability of DC-SIGN in
terms of dynamics (26–28). We decided to thoroughly investi-
gate the lateral mobility of DC-SIGN on both CHO and imDCs
FIGURE 3. Truncation of neck region affects DC-SIGN nanoclustering.
A, representative TEM images of whole-mount, immunogold-labeled CHO
cells expressing DC-SIGN-wt (top) and DC-SIGN-Rep (bottom). Anti-AU1
mAb and 10-nm Ø gold particles were used to specifically stain DC-SIGN.
Results are representative of multiple cells in several independent experi-
ments. B, the digital images of electron micrographs were processed by cus-
tom-written software based on Matlab (see supplemental Methods) to
extract the percentage of DC-SIGN molecules organized in nanoclusters for
DC-SIGN-wt and the different mutants (-CRD, -Rep, and -35). The results
are compared with simulations of random organization with similar surface
density as in the experiments. A t test was used to compare the data of DC-
SIGN-wt with DC-SIGN-CRD data and to compare DC-SIGN-35 data with
DC-SIGN-Rep data (*, p 105). C, probability distribution of the number of
particles per nanocluster frommultiple TEM images over at least three inde-
pendent experiments comparedwith simulation of randomdistributionwith
the same surfacedensity as in the experiments. Lines areguides for the eye. At
least 10different TEM imagesover different cells are shownat each condition.
Error bars, S.D.
DC-SIGN Structure Relates Distribution to Function
38950 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287•NUMBER 46•NOVEMBER 9, 2012
 at UNIVERSITEIT TW









using particle tracking (SPT) of quantum dots (Qdot) specifi-
cally labeling DC-SIGN, at high speed (60 frame/s) and 20-nm
localization accuracy. To avoid potential artifacts due to inter-
actions between the cell ventral membrane and the substrate,
we performedQdot labeling of DC-SIGN (either using biotiny-
lated anti-DC-SIGN DCN46 Fab or anti-AU1 single-chain Ab)
after cell stretching and recorded individual trajectories exclu-
sively on the dorsal membrane. Clear mobility of DC-SIGN-wt
nanoclusters and DC-SIGN-Rep was observed on CHO cells
(Fig. 6A and supplemental Movies 1–4) in apparent contrast to
the results obtained on NIH-3T3 cells (27, 28).
To quantify the degree of mobility of DC-SIGN, we built
individual trajectories from multiple movies and generated
plots of the mean squared displacement as a function of time
lag. Apparent diffusion coefficients D2–4 were calculated from
the initial slopes by linear fit from the second to the fourth point
and included in a semilog plot (Fig. 6B). The D2–4 values of
DC-SIGN-wt nanoclusters varied from 103 to 101 m2/s,
with a median value ofD2–4 6.5 102 m2/s. On the other
hand, the D2–4 distribution of DC-SIGN-Rep was signifi-
cantly narrower and shifted to largerD2–4 values, with amedian
value ofD2–4 1.23 101m2/s. Because the diffusion coef-
ficient D depends on the size of the diffusing object R as D 	
1/R, the higherD2–4 values observed on DC-SIGN-Rep com-
pared with those of DC-SIGN-wt are entirely consistent with
nanocluster dissolution (38, 39).
To validate our results on CHO cells, we performed single
Qdot tracking of endogenous DC-SIGN nanoclusters on
monocyte-derived imDCs. Apparent mobility was also
observed on the dorsal membrane of imDCs (Fig. 6A and sup-
plemental Movies 5 and 6), with D2–4 values comparable with
those obtained for DC-SIGN-wt on CHO cells (Fig. 6C).
BecauseD2–4 does not report on the long term diffusion behav-
ior we then generated cumulative mean squared displacement
plots of all trajectories at longer time lags for DC-SIGN-wt,
DC-SIGN-Rep on CHO, and DC-SIGN on imDCs (Fig. 6D).
In all the three cases, the plots are nearly linear, indicating
Brownian diffusion of DC-SIGN on both imDCs and CHO
cells. As expected, the average D value of DC-SIGN-Rep, as
extracted from the slope of the cumulative mean squared dis-
placement plot, is higher than that of DC-SIGN-wt. Moreover,
the immobile fraction (D 6 104m2/s) ofDC-SIGN in the
FIGURE 4. Superresolution optical nanoscopy confirms loss of nanoclus-
tering for DC-SIGN-Rep. A–D, confocal (A and C) and counterpart STED
(B and D) images of DC-SIGN-wt (A and B) and DC-SIGN-Rep (C and D) on
CHO cells. The insets highlight the increased resolution of STED compared
withdiffraction-limited confocalmicroscopy. ImageswereobtainedonaCW-
STED system (Leica Microsystems), with a 100/1.4 numerical aperture oil
immersion objective (HCX PL APO, Leica Microsystems). E, normalized distri-
bution of the spot sizes obtained for DC-SIGN-wt (gray bars) compared with
that of DC-SIGN-Rep (dotted area). The average spot sizes are 186 nm (55
nm) and 108 nm (24 nm) for DC-SIGN-wt and -Rep, respectively. The inset
shows the spot sizesobtained from individualAbsnonspecifically attached to
glass and are used to illustrate the spatial resolution of STED (100 nm).
F, normalized intensity distribution of fluorescent spots obtained for
DC-SIGN-wt (gray bars) compared with that of DC-SIGN-Rep (dotted area).
The inset shows the corresponding intensity of spots found on glass. Shown
are 266 and 198 spots of DC-SIGN-wt and -Rep, respectively, frommultiple
STED images.
FIGURE 5.NSOMconfirmsDC-SIGNnanoclustering on imDC. A and B, con-
focal (A) and counterpart NSOM (B) images of DC-SIGN on imDC. The insets
highlight the increased resolution of NSOM compared with diffraction-lim-
ited confocal microscopy. Images were obtained on a custom-built NSOM/
confocal microscope (Zeiss Axiovert), with a100/1.3 numerical aperture oil
immersion objective (Zeiss). C, normalized distribution of the spot sizes
obtained for DC-SIGN on imDC (dotted area) comparedwith that of CHO cells
expressing DC-SIGN-wt (gray bars). The inset shows the spot sizes obtained
from individualAbsnonspecifically attached toglass andareused to illustrate
the spatial resolution of NSOM (100 nm). D, normalized intensity distribu-
tion of fluorescent spots obtained for DC-SIGN on imDC (dotted area) com-
pared with that of CHO cells expressing DC-SIGN-wt (gray bars). The inset
shows the corresponding intensity of spots found on glass.
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three cases accounted for 10% of all trajectories analyzed.
These results thus conclusively confirm lateral mobility of DC-
SIGN nanoclusters within the cell membrane and further evi-
dence a faster diffusion of DC-SIGN-Rep fully consistent with
nanocluster dissolution at the cell membrane.
Monte Carlo Simulations Indicate That DC-SIGNNanoclus-
tering Enhances Viral Binding Ability—Because the decreased
capability of DC-SIGN-Rep to bind to virus-sized particles
correlated with a loss of nanoclustering on the cell membrane,
we wished to understand the impact of receptor organization
and, in particular, the role of DC-SIGN nanoclustering on viral
binding. For this, we turned toMonte Carlo simulations, where
we considered different degrees of receptor organization and
allowed pathogens of different sizes to land on the cell mem-
brane. We first sought to investigate the role of receptor clus-
tering as a function of pathogen size by choosing two extreme
cases (i.e.pathogenswith sizes comparablewith those of viruses
(r 50 nm) and pathogens with sizes comparable with those of
bacteria (r  500 nm)) (Fig. 7A). As schematically depicted in
Fig. 7A, pathogens are approximated as spheres of radius r and
the membrane as a flat square region with lateral size L 

 r.
Receptormolecules are positioned on themembrane according
to different spatial distributions, varying the degree of cluster-
ing, from completely random to fully clustered. In the simula-
tions, the pathogen lands at a randomposition on the cellmem-
brane, and the number of DC-SIGN receptors (n) within the
area projected by the pathogen is counted. From these data, the
complementary cumulative distribution function (ccdf) is
obtained and plotted versus n. The ccdf value for a given n rep-
resents the probability that at least n receptors are accessible to
the pathogen at the moment of membrane contact. This quan-
tity is important for pathogen binding because the larger the
number of accessible receptorsn, themore likely it is for ligands
on the pathogen surface to engage specific bonds with the
membrane receptors.
First, we investigated the effect of receptor nanoclustering on
virus binding (r  50 nm) while keeping constant the total
receptor density. As the percentage of clustering is increased,
the ccdf decays at higher n, indicating an increased probability
of having more accessible receptors around the virus contact
point (Fig. 7B). Taking as a reference the value of n 4 (dashed
vertical line), the corresponding ccdf varies over more than 2
orders of magnitude as a function of the clustering percentage,
from104 for random organization, to102 for total clus-
tering. Importantly, a slight increase in clustering percentage
from60 to 80%, similarly towhat is observed in theTEM images
for DC-SIGN-Rep and -wt, respectively, already produces a
5-fold probability enhancement.
Although a qualitatively similar effect is also visible for larger
pathogen-like particles (r  500 nm), the increased clustering
induces a much smaller variation. Indeed, a change from ran-
dom distribution to 80% clustering induces at most a 5-fold
increase in the ccdf (n  30), and a significant change is only
observed in the case of total clustering for n
 40. Our simula-
tions thus confirm that nanoclustering has a crucial role for the
docking of virus-sized particles and provides a mechanistic
explanation for the distinct binding capabilities of DC-SIGN by
correlating pathogen size with DC-SIGN spatial organization.
FIGURE 6. DC-SIGN nanoclusters are freely mobile on CHO cells and
imDCs. A, selected sample time series of DC-SIGN-Qdots to illustrate the
mobility of DC-SIGN-wt (left), DC-SIGN-DRep (middle), and DC-SIGN on imDC
(right) (see supplemental Movies 1–6). Scale bar, 1 m. Experiments were
performed using a custom single-molecule sensitive epifluorescence micro-
scope equipped with a63/1.2 numerical aperture water immersion objec-
tive (Olympus) and an EM-CCD camera (Hamamatsu). B, normalized semilog
distribution of D2–4 values at short time lags for DC-SIGN-wt (gray bars) and
DC-SIGN-Rep (dotted area). Eachhistogramcontains at least 100 trajectories
taken from 
50 cells in multiple experiments. C, normalized semilog distri-
bution of D2–4 values at short time lags for DC-SIGN-wt (gray bars) and DC-
SIGNon imDC (dottedarea). At least 250 trajectories/histogramfrom
40cells
in multiple experiments were analyzed. D, cumulative mean squared displace-
ment plots of DC-SIGN-wt (black), DC-SIGN-Rep (blue), and DC-SIGN on imDC
(magenta). The inset shows the percentage of trajectories withD2–4 6 10
4
m2/s and classified as immobile. Error bars, S.D.
FIGURE 7.Monte Carlo simulations show the effect of nanoclustering on
pathogenbinding.A, schematicsof the simulationofpathogen landingover
a cell membrane containing receptors spatially distributed in a random or
clustered fashion. B, complementary cumulative distribution function (ccdf)
for having a given number of receptors at the pathogen-cell interface for two
pathogen radii (50 and 500 nm) at different degrees of nanoclustering (black,
randomdistribution; red, 60% clustering; blue, 80% clustering; green, full clus-
tering). C, ccdf for having a given number of receptors at the pathogen-cell
interface for different cluster densities. The thick black linedenotes the exper-
imental distribution.
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Heterogeneity in Cluster Density Confers Broader Binding
Capability to DC-SIGN—TEM and superresolution images
showed that DC-SIGN organizes in nanoclusters having a
broadly distributed size and number of particles (Figs. 3C and 4,
E and F). To inquire whether this multidispersed distribution
offers any advantage with respect to a monodispersed type of
clustering, we performedMonte Carlo simulations, varying the
number of receptors per cluster, assuming that the cluster size
depends linearly on the number of receptors per cluster (sup-
plemental Fig. S3D). As expected, the presence of clusters
formed by a larger number of receptors progressively shifted
the ccdf decay toward larger n (Fig. 7C). Interestingly, the ccdf
obtained for the experimental distribution ofnclust (black curve)
initially follows the same behavior as that simulated for nclust
3, to then decay similarly as nclust  5 and finally overlapping
with the ccdf simulated for nclust 8. Therefore, these simula-
tions show that the heterogeneity experimentally observed for
the molecular density of DC-SIGN nanoclusters might serve to
effectively broaden its binding capabilities to a variety of viruses
having different sizes and/or binding affinities for DC-SIGN.
Lateral mobility of nanoclusters, as observed in our experi-
ments, will then further virus capture by increasing the proba-
bility of encountering events.
DISCUSSION
It has been extensively documented that DC-SIGN forms
stable tetramers both in vitro and in living cells (21–23, 37).
Tetramers would allow the establishment of multivalent inter-
actions via the CRDs, increasing the adhesion energy of DC-
SIGN to its ligands. Our results now show a higher level of
spatial complexity of DC-SIGN at the cell membrane and dem-
onstrate for the first time a direct structural relationship
between tetramer stability and nanoclustering formation sus-
tained by the neck region of DC-SIGN. Furthermore, this par-
ticular arrangement appeared crucial for efficient binding of
nanometer scale pathogens, such as viruses, underscoring a
physiological role for nanoclustering. Thus, our work provides
a clear example of self-organization at the cell surface prior to
ligand activation that is driven by themolecular structure of the
receptor.
It has been proposed that the extended and flexible structure
of theDC-SIGNneck regionmight play a role in favorably posi-
tioning the CRDs for efficient pathogen binding (21, 22) and
that neck-truncated molecules did not bind to HIV-1 because
they are too short to emerge from the plasma membrane (30).
Our binding assays show that the CRD of the neck-truncated
mutant is fully available for binding to both soluble ligands and
micrometer-sized objects and that the impaired binding to
virus-like particles is mostly due to the lack of nanocluster spa-
tial organization of DC-SIGN. We also observed that
DC-SIGN-mediated internalization was independent of the
neck region but highly affected by the cytoplasmic tail of DC-
SIGN. These results thus reflect different functional properties
of DC-SIGN directly related to its molecular structure (i.e.
whereas nanoclustering is important for pathogen binding, the
cytoplasmic region determines internalization efficiency).
Recent work using diffraction-limited confocal imaging
showed that on imDCs and fibroblast cell lines, DC-SIGN form
immobilemicrodomains of dimensions larger than 600 nm sta-
bilized by interactions between the CRDs and the extracellular
matrix (26–28). Deletion of theCRDabrogatedmicroclustering
and resulted in DC-SIGN lateral diffusion on the cell mem-
brane, asmeasured by fluorescence recovery after photobleach-
ing using full Abs (28). In apparent contrast, we observed that
truncation of the CRDs did not affect the nanoclustering capac-
ity of DC-SIGN and that nanoclusters are fully mobile, inde-
pendent of the cell type andmutant investigated. Because of the
limited spatial resolution of confocal microscopy, it might well
be that nanoclusters (of sizes 180 nm as observed in our
superresolution experiments) spatially proximal to each other
appear as larger clusters when inspected by confocal micros-
copy. Indeed, recent work from the same group using super-
resolution blink microscopy showed that the microdomains
observed by diffraction-limited optical techniques are in fact
composed of discreteDC-SIGNnanodomains (40). In addition,
receptor diffusion measurements on the cell membrane are
highly influenced by the labeling conditions.Whereas the use of
full Abs might induce cross-linking of close by receptors
increasing clustering beyond the native state and reducing their
overallmobility to the level of fixed cells (41, 42), single chainsor
Fabs, asused inour experiments, guarantee thatbothnanocluster-
ing and lateral mobility are minimally influenced. Additionally,
possible Ab-induced receptor cross-linking could contribute to
initiate DC-SIGN endocytosis via nascent clathrin-coated pits.
These nascent endocytic complexes are likely to appear as immo-
bile features at the observed time scale.
In summary, we have shown that homophilic interactions
mediated by the neck region of DC-SIGN are essential to coor-
dinate its spatiotemporal organization on the cell membrane,
effectively broadening its binding capabilities to nanoscale-
sized pathogens. Because lateral mobility of receptors and
ligands plays a key role in facilitating mutual interactions, our
results indicate that for a given number of receptors at the cell
surface, tight spatial coordination in nanoclusters guarantees
highly energetic interactions with ligands, whereas lateral
mobility enhances the probability of encountering the ligand
for effective binding.
Interestingly, different DC-SIGN neck variants have been
found to naturally occur on dendritic and myeloid cells (37),
and polymorphisms in the DC-SIGN gene affecting the length
of the neck region appeared to be correlated with altered sus-
ceptibility toHIV infection (43, 44). AlsowithHIV,DC-SIGN is
known to interact with a plethora of viruses with different sizes
andproperties.WhereasDC-SIGNhas been shown to solely act
as an attachment factor for viruses such as ebola (45), measles
(46), and hepatitis C (47), recent publications have demon-
strated the direct involvement of DC-SIGN in the entry of
viruses, such as arthropod-borne phleboviruses (48), coronavi-
rus (49), and human herpesvirus 8 (50). Clearly, DC-SIGN
binds with equal efficiency to viruses of different sizes (from
Dengue (50 nm) to HIV (100 nm) and measles virus (200–
300nm)).Our grouphas already shown thatDC-SIGN is able to
bind to gp120-coated particles of 40 nm in size as well as real
HIV virions (11). In addition, Pohlmann et al. (30) have
reported that real HIV virus cannot bind to DC-SIGN-Rep,
implying that 40 nm and 100 nm are equally not bound by this
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mutant. Our work therefore demonstrates that the plasticity of
DC-SIGN virus binding capacity is largely determined by its
variable nanoclustering capacity, which is regulated by the neck
region of the receptor. Furthermore, our simulations indicate
that the number of receptors included in the clusters defines
the effectiveness of the binding as long as the sizes of the viruses
are comparablewith the sizes of theDC-SIGNnanoclusters (i.e.
from 80 to 400 nm with a mean size of 180 nm). Thus, the
inherent nanoclustering ofDC-SIGNdriven by the neck region,
as observed in our measurements, could have important impli-
cations for DC-SIGN functionality under physiological settings
and impact our understanding of membrane receptor organi-
zation in relation to virus entry into the cells.
We recently demonstrated that ligand binding via the DC-
SIGN neck region leads to prolonged antigen storage and
enhanced cross-presentation capacity (43). Exploitation of the
DC-SIGN neck region therefore represents an intriguing pos-
sibility for the development of novel targeted vaccination strat-
egies, justifying the increasing interest in the contribution of
the neck region to the immunobiology of DC-SIGN.
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